相似文献
1
Regulation of osteoclast-mediated bone resorption by microRNA.
Cell Mol Life Sci. 2022 May 10;79(6):287. doi: 10.1007/s00018-022-04298-y.
2
Estrogen inhibits osteoclasts formation and bone resorption via microRNA-27a targeting PPARγ and APC.
J Cell Physiol. 2018 Jan;234(1):581-594. doi: 10.1002/jcp.26788. Epub 2018 Sep 10.
3
MicroRNA-17/20a inhibits glucocorticoid-induced osteoclast differentiation and function through targeting RANKL expression in osteoblast cells.
Bone. 2014 Nov;68:67-75. doi: 10.1016/j.bone.2014.08.004. Epub 2014 Aug 17.
4
Osteoclast signaling-targeting miR-146a-3p and miR-155-5p are downregulated in Paget's disease of bone.
Biochim Biophys Acta Mol Basis Dis. 2020 Oct 1;1866(10):165852. doi: 10.1016/j.bbadis.2020.165852. Epub 2020 May 30.
5
miR-31 controls osteoclast formation and bone resorption by targeting RhoA.
Arthritis Res Ther. 2013;15(5):R102. doi: 10.1186/ar4282.
6
The fungal metabolite (+)-terrein abrogates osteoclast differentiation via suppression of the RANKL signaling pathway through NFATc1.
Int Immunopharmacol. 2020 Jun;83:106429. doi: 10.1016/j.intimp.2020.106429. Epub 2020 Mar 26.
7
AMPKα1 negatively regulates osteoclastogenesis and mitigates pathological bone loss.
J Biol Chem. 2023 Dec;299(12):105379. doi: 10.1016/j.jbc.2023.105379. Epub 2023 Oct 21.
8
Brevilin A inhibits RANKL-induced osteoclast differentiation and bone resorption.
In Vitro Cell Dev Biol Anim. 2023 Jun;59(6):420-430. doi: 10.1007/s11626-023-00783-1. Epub 2023 Jul 17.
9
MicroRNA-338-3p inhibits glucocorticoid-induced osteoclast formation through RANKL targeting.
Genet Mol Res. 2016 Aug 26;15(3):gmr7674. doi: 10.4238/gmr.15037674.
10
Inhibition of Osteoclastogenesis and Bone Resorption in vitro and in vivo by a prenylflavonoid xanthohumol from hops.
Sci Rep. 2015 Dec 1;5:17605. doi: 10.1038/srep17605.
引用本文的文献
1
Dual role of autophagy in bone metastasis: mechanistic insights and therapeutic targeting.
Am J Clin Exp Urol. 2025 Apr 25;13(2):92-117. doi: 10.62347/QCPV6064. eCollection 2025.
2
The underlying mechanisms of the association of bone health with depression - an experimental study.
Mol Biol Rep. 2025 Jan 27;52(1):163. doi: 10.1007/s11033-025-10230-x.
3
Anti-osteoporosis mechanism of resistance exercise in ovariectomized rats based on transcriptome analysis: a pilot study.
Front Endocrinol (Lausanne). 2023 Aug 17;14:1162415. doi: 10.3389/fendo.2023.1162415. eCollection 2023.
4
Role of noncoding RNAs in orthodontic tooth movement: new insights into periodontium remodeling.
J Transl Med. 2023 Feb 9;21(1):101. doi: 10.1186/s12967-023-03951-9.
5
The monocyte-to-osteoclast transition in rheumatoid arthritis: Recent findings.
Front Immunol. 2022 Sep 12;13:998554. doi: 10.3389/fimmu.2022.998554. eCollection 2022.
6
KYMASIN UP Natural Product Inhibits Osteoclastogenesis and Improves Osteoblast Activity by Modulating Src and p38 MAPK.
Nutrients. 2022 Jul 25;14(15):3053. doi: 10.3390/nu14153053.
本文引用的文献
1
STAT3 is critical for skeletal development and bone homeostasis by regulating osteogenesis.
Nat Commun. 2021 Nov 25;12(1):6891. doi: 10.1038/s41467-021-27273-w.
2
Exosomes derived from PC-3 cells suppress osteoclast differentiation by downregulating miR-148a and blocking the PI3K/AKT/mTOR pathway.
Exp Ther Med. 2021 Nov;22(5):1304. doi: 10.3892/etm.2021.10739. Epub 2021 Sep 16.
3
Osteoblasts-derived exosomes regulate osteoclast differentiation through miR-503-3p/Hpse axis.
Acta Histochem. 2021 Oct;123(7):151790. doi: 10.1016/j.acthis.2021.151790. Epub 2021 Sep 27.
4
MicroRNA-21: An Emerging Player in Bone Diseases.
Front Pharmacol. 2021 Sep 7;12:722804. doi: 10.3389/fphar.2021.722804. eCollection 2021.
5
Non-small cell lung cancer cell-derived exosomal miR-17-5p promotes osteoclast differentiation by targeting PTEN.
Exp Cell Res. 2021 Nov 1;408(1):112834. doi: 10.1016/j.yexcr.2021.112834. Epub 2021 Sep 16.
6
miRNA-7062-5p Promoting Bone Resorption After Bone Metastasis of Colorectal Cancer Through Inhibiting GPR65.
Front Cell Dev Biol. 2021 Aug 17;9:681968. doi: 10.3389/fcell.2021.681968. eCollection 2021.
7
Exosomal miR-19a and IBSP cooperate to induce osteolytic bone metastasis of estrogen receptor-positive breast cancer.
Nat Commun. 2021 Aug 31;12(1):5196. doi: 10.1038/s41467-021-25473-y.
8
Runx1/miR-26a/Jagged1 signaling axis controls osteoclastogenesis and alleviates orthodontically induced inflammatory root resorption.
Int Immunopharmacol. 2021 Nov;100:107991. doi: 10.1016/j.intimp.2021.107991. Epub 2021 Aug 23.
9
GATA4-driven miR-206-3p signatures control orofacial bone development by regulating osteogenic and osteoclastic activity.
Theranostics. 2021 Jul 25;11(17):8379-8395. doi: 10.7150/thno.58052. eCollection 2021.
10
Tumour-derived exosomal lncRNA-SOX2OT promotes bone metastasis of non-small cell lung cancer by targeting the miRNA-194-5p/RAC1 signalling axis in osteoclasts.
Cell Death Dis. 2021 Jul 2;12(7):662. doi: 10.1038/s41419-021-03928-w.
Zotero 插件